These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Lee R; Localio AR; Armstrong K; Malkowicz SB; Schwartz JS; Urology; 2006 Apr; 67(4):762-8. PubMed ID: 16600352 [TBL] [Abstract][Full Text] [Related]
4. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815 [TBL] [Abstract][Full Text] [Related]
5. [Prostate-specific antigen and its related parameters in detecting prostate cancer]. Kuruma H; Egawa S Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698 [TBL] [Abstract][Full Text] [Related]
7. [Prostatic specific antigen: role and significance in urologic practice]. Manolović D; Pejcić T; Milović N Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420 [TBL] [Abstract][Full Text] [Related]
8. PSA and other tissue kallikreins for prostate cancer detection. Stephan C; Jung K; Lein M; Diamandis EP Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069 [TBL] [Abstract][Full Text] [Related]
9. I recently read that a urologist who has studied the prostate-specific antigen (PSA) test has now concluded that PSA is virtually useless as a screening tool for prostate cancer. Is this true? Johns Hopkins Med Lett Health After 50; 2005 Feb; 16(12):8. PubMed ID: 15772996 [No Abstract] [Full Text] [Related]
10. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Lilja H; Ulmert D; Vickers AJ Nat Rev Cancer; 2008 Apr; 8(4):268-78. PubMed ID: 18337732 [TBL] [Abstract][Full Text] [Related]
11. [Value of prostate specific antigen in early diagnosis of prostatic cancer]. Xiao LP; Bi XJ; Li YN; Chen XQ; Zhang XF; Yu XP; Liu G; Yang MC; Song Z Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer with low PSA levels. Glaser AI N Engl J Med; 2004 Oct; 351(17):1802-3. PubMed ID: 15499670 [No Abstract] [Full Text] [Related]
14. Pro PSA : a "pro cancer" form of PSA? Peyromaure M; Fulla Y; Debré B; Dinh-Xuan AT Med Hypotheses; 2005; 64(1):92-5. PubMed ID: 15533620 [TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters. Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer detection: beware of the low PSA. Haas GP Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742 [No Abstract] [Full Text] [Related]
18. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management]. Malmström PU Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565 [No Abstract] [Full Text] [Related]
19. [Early detection of prostatic carcinoma: Is PSA screening suitable?]. Kaulen H Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136 [No Abstract] [Full Text] [Related]